OracleBio will be attending the 5th Digital Pathology & AI Congress, which takes place from the 6th to the 7th of December 2018 in London, UK.
OracleBio provides a range of digital pathology image analysis services that support pre-clinical and clinical immuno-oncology R&D. Using immunohistochemistry and immunoflourescence techniques, we are able to produce a variety of quantifiable results valuable to immuno-oncology research, such as immune cell number, immune cell co-localisation and spatial distribution within the tumor microenvironment. To find out more about OracleBio’s immuno-oncology services, please click here.
Returning to London for its 5th year, the Digital Pathology & AI Congress will provide a unique opportunity to take home cutting-edge strategies, analysis techniques, case study examples and methods to fully understand both the technology and accompanying informatics and image analysis tools and utilize digital pathology to its greatest potential. The 2018 meeting has expanded coverage of new areas such as AI and computational pathology alongside the latest case studies and applications. To find out more about the event, please click here.
OracleBio’s Chief Scientific Officer Lorcan Sherry and Clinical Operations Manager Alison Bigley will be in attendance throughout the congress. If you would like to learn more about OracleBio’s services, or wish to arrange a time to speak with the OracleBio team during the event, please contact us.
OracleBio will also be presenting a poster entitled ‘Utilization of fluorescent multiplex IHC and digital image analysis for studying LAG-3, CD3 and CD8 positive TIL subsets in NSCLC tissue‘. Click here to view or download the poster.
To keep up to date with all OracleBio news and events, please follow us on LinkedIn by clicking the button below: